Rel blocks both anti-Fas and TNFα-induced apoptosis and an intact Rel transactivation domain is essential for this effect

被引:40
作者
Zong, WX
Bash, J
Gélinas, C
机构
[1] CABM, Piscataway, NJ 08854 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Program Biochem & Mol Biol, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Grad Program Microbiol & Mol Genet, Piscataway, NJ 08854 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA
[5] Inst Canc New Jersey, Piscataway, NJ 08854 USA
关键词
Rel; NF-kappa B; apoptosis; TNF alpha; Fas;
D O I
10.1038/sj.cdd.4400441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The v-Rel oncoprotein must be continuously expressed to prevent the apoptosis of transformed lymphoid cells, and also inhibits TNF alpha-induced cell death. A tetracycline-regulated cell system was used to characterize the functions necessary for the anti-apoptotic activity of Rel proteins. v-Rel mutants defective for DNA binding or transactivation showed no protective effect. Similarly, whereas the transcription-competent c-Rel and RelA proteins inhibited TNF alpha-induced cytolysis, the transactivation-negative p50/NF-kappa B1 did not. Importantly, this study is the first to show that c-Rel can also confer significant protection from Fas-mediated cell death. Since the TNFR1- and Fas-signaling pathways involve some intermediates that are common and others that are unique to each pathway, these findings indicate that c-Rel may regulate the expression of genes that function to antagonize either or both death-signaling pathways.
引用
收藏
页码:963 / 972
页数:10
相关论文
共 55 条
  • [1] HIGH-LEVELS OF C-REL EXPRESSION ARE ASSOCIATED WITH PROGRAMMED CELL-DEATH IN THE DEVELOPING AVIAN EMBRYO AND IN BONE-MARROW CELLS IN-VITRO
    ABBADIE, C
    KABRUN, N
    BOUALI, F
    SMARDOVA, J
    STEHELIN, D
    VANDENBUNDER, B
    ENRIETTO, PJ
    [J]. CELL, 1993, 75 (05) : 899 - 912
  • [2] Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors
    Armstrong, RC
    Aja, T
    Xiang, JL
    Gaur, S
    Krebs, JF
    Hoang, K
    Bai, X
    Korsmeyer, J
    Karanewsky, DS
    Fritz, LC
    Tomaselli, KJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) : 16850 - 16855
  • [3] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [4] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [5] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [6] c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G(1)/S-phase transition
    Bash, J
    Zong, WX
    Gelinas, C
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) : 6526 - 6536
  • [7] An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
    Beg, AA
    Baltimore, D
    [J]. SCIENCE, 1996, 274 (5288) : 782 - 784
  • [8] CONSTITUTIVE NF-KAPPA-B ACTIVATION, ENHANCED GRANULOPOIESIS, AND NEONATAL LETHALITY IN I-KAPPA-B-ALPHA-DEFICIENT MICE
    BEG, AA
    SHA, WC
    BRONSON, RT
    BALTIMORE, D
    [J]. GENES & DEVELOPMENT, 1995, 9 (22) : 2736 - 2746
  • [9] STRUCTURE OF THE HUMAN APO-1 GENE
    BEHRMANN, I
    WALCZAK, H
    KRAMMER, PH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) : 3057 - 3062
  • [10] CONSTRUCTION OF A FUSION GENE THAT CONFERS RESISTANCE AGAINST HYGROMYCIN-B TO MAMMALIAN-CELLS IN CULTURE
    BERNARD, HU
    KRAMMER, G
    ROWEKAMP, WG
    [J]. EXPERIMENTAL CELL RESEARCH, 1985, 158 (01) : 237 - 243